Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
Recurrence and metastasis are commonly associated with poor prognosis of hepatocellular carcinoma (HCC). Therefore, a better understanding of molecular mechanisms involved in HCC metastasis may lead to more effective treatment for HCC patients. Rac plays important roles in cytoskeletal reorganization leading to cell motility in renal and breast carcinomas. However, the role of Rac is controversial in tumors and has not been studied in HCC. The aim of this study was to investigate the importance of the Rac signaling pathway in HCC cell motility and the anti-metastatic potential of FTY720. Recently a pair of HCC cell lines from a primary tumor (H2P) and its matched metastasis (H2M) was established. These two cell lines provide a useful tool for the study of HCC metastasis. The results show that the Rac signaling pathway is activated in the metastatic HCC cell line (H2M) compared with the primary HCC cell line (H2P). FTY720 specifically suppressed H2M cell motility by down-regulation of the Rac-GTP level through inhibition of phosphoinositide 3-kinase activity. To conclude, this study is the first to demonstrate an essential role of Rac signaling pathway activation in HCC metastasis and suppression of cell motility by FTY720 through blocking of the Rac pathway.
Lee
Terence K
TK
Centre for the Study of Liver Disease, University of Hong Kong, Pokfulam, Hong Kong, China.
Man
Kwan
K
Ho
Joanna W
JW
Wang
Xiang Hong
XH
Poon
Ronnie T
RT
Sun
Chris K
CK
Ng
Kevin T
KT
Ng
Irene O
IO
Xu
Ray
R
Fan
Sheung Tat
ST
D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement; D000068876:Fingolimod Hydrochloride; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D020935:MAP Kinase Signaling System / Q000187:drug effects; D009362:Neoplasm Metastasis; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011409:Propylene Glycols / Q000494:pharmacology; D015398:Signal Transduction; D013110:Sphingosine / Q000031:analogs & derivatives; D020744:rac GTP-Binding Proteins / Q000378:metabolism*
D000068876:Fingolimod Hydrochloride; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011409:Propylene Glycols; D013110:Sphingosine; D020744:rac GTP-Binding Proteins